LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Trial Identifier: D133HR00044
Sponsor: AstraZeneca
Start Date: August 2025
Primary Completion Date: September 2027
Study Completion Date: September 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.